The CMUH Stroke Center has an outstanding team with leaders in disciplines centered on treating cerebrovascular diseases.
The Stroke Center closely collaborates with stroke leaders at the Harvard University, Yale University, Stanford University, Washington University in St. Louis, University of California (at San Francisco, Los Angeles, and San Diego), The National Institutes of Health, Cornell University, University of Washington, and University of British Columbia.
The Stroke Center is also conducting nation-wide stroke research projects and multi-center trials on strokes; these projects are built on a network of 39 stroke centers across the country and a national stroke registry, which has enrolled more than 46,000 stroke admissions and is currently the second largest in the world.
Stem Cell Research and Clinical Trials
At the Stroke Center, research teams are studying stem cells and developing related therapies, with priorities directed at improving the functional outcomes in stroke patients. The center also has the first GTP-grade laboratory in Taiwan, with the unique credentials of being the first in the world to conduct Phase I and Phase II trials on the autologous transplantation of peripheral blood-derived stem cells in stroke patients.
Stroke Center personnel have studied the applications of an array of medical devices for treating or preventing stroke, as well as restoring neural function in patients with various neurological diseases. This research was based on state-of-the art electronic and biomaterial approaches developed in collaboration with National Chiao-Tung University (交通大學), which is internationally renowned for chip technology and bio-medical engineering.
Community Medicine Network
Finally, the Stroke Center boasts the most comprehensive community medicine network in the nation for applying creative measures to lower stroke burden, as well as telemedicine services to advance cost-effective care for patients disabled by stroke or other neurological disorders.